Evaluation of Metabolically Stabilized Angiotensin IV Analogs as Procognitive/Antidementia Agents
Open Access
- 1 January 2013
- journal article
- research article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 344 (1) , 141-154
Abstract
Angiotensin IV (AngIV: VYIHPF)–related peptides have long been recognized as procognitive agents with potential as antidementia therapeutics. Their development as useful therapeutics, however, has been limited by physiochemical properties that make them susceptible to metabolic degradation and impermeable to gut and blood-brain barriers. A previous study demonstrated that the core structural information required to impart the procognitive activity of the AngIV analog, norleucine1-angiotensin IV, resides in its three N-terminal amino acids, Nle-Tyr-Ile. The goal of this project was to chemically modify this tripeptide in such a way to enhance its metabolic stability and barrier permeability to produce a drug candidate with potential clinical utility. Initial results demonstrated that several N- and C-terminal modifications lead to dramatically improved stability while maintaining the capability to reverse scopolamine-induced deficits in Morris water maze performance and augment hippocampal synaptogenesis. Subsequent chemical modifications, which were designed to increase hydrophobicity and decrease hydrogen bonding, yielded an orally active, blood-barrier permeant, metabolically stabilized analog, N-hexanoic-Tyr-Ile-(6) aminohexanoic amide (dihexa), that exhibits excellent antidementia activity in the scopolamine and aged rat models and marked synaptogenic activity. These data suggest that dihexa may have therapeutic potential as a treatment of disorders, such as Alzheimer’s disease, where augmented synaptic connectivity may be beneficial.Keywords
This publication has 44 references indexed in Scilit:
- The Hepatocyte Growth Factor/c-Met Antagonist, Divalinal-Angiotensin IV, Blocks the Acquisition of Methamphetamine Dependent Conditioned Place Preference in RatsBrain Sciences, 2012
- Facilitation of Hippocampal Synaptogenesis and Spatial Memory by C-Terminal Truncated Nle1-Angiotensin IV AnalogsThe Journal of Pharmacology and Experimental Therapeutics, 2011
- The Angiotensin IV Analog Nle-Tyr-Leu-ψ-(CH2-NH2)3-4-His-Pro-Phe (Norleual) Can Act as a Hepatocyte Growth Factor/c-Met InhibitorThe Journal of Pharmacology and Experimental Therapeutics, 2010
- Structural dynamics of dendritic spines in memory and cognitionTrends in Neurosciences, 2010
- Nerve growth factor as a paradigm of neurotrophins related to Alzheimer's diseaseDevelopmental Neurobiology, 2010
- Principles of Long-Term Dynamics of Dendritic SpinesJournal of Neuroscience, 2008
- Cognitive-enhancing effects of angiotensin IVBMC Neuroscience, 2008
- An activity-regulated microRNA controls dendritic plasticity by down-regulating p250GAPProceedings of the National Academy of Sciences, 2008
- Design and validation of a tool for neurite tracing and analysis in fluorescence microscopy imagesCytometry Part A, 2004
- Angiotensin IV in the central nervous systemCell and tissue research, 2003